Gotowa bibliografia na temat „Liposomes”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Liposomes”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Liposomes"
Al Badri, Yaqeen Nadheer, Cheng Shu Chaw i Amal Ali Elkordy. "Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics". Pharmaceutics 15, nr 1 (15.01.2023): 294. http://dx.doi.org/10.3390/pharmaceutics15010294.
Pełny tekst źródłaIshida, Tatsuhiro, Hideyoshi Harashima i Hiroshi Kiwada. "Liposome Clearance". Bioscience Reports 22, nr 2 (1.04.2002): 197–224. http://dx.doi.org/10.1023/a:1020134521778.
Pełny tekst źródłaCattel, Luigi, Maurizio Ceruti i Franco Dosio. "From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy". Tumori Journal 89, nr 3 (maj 2003): 237–49. http://dx.doi.org/10.1177/030089160308900302.
Pełny tekst źródłaYanagihara, Shin, Yukiya Kitayama, Eiji Yuba i Atsushi Harada. "Preparing Size-Controlled Liposomes Modified with Polysaccharide Derivatives for pH-Responsive Drug Delivery Applications". Life 13, nr 11 (3.11.2023): 2158. http://dx.doi.org/10.3390/life13112158.
Pełny tekst źródłaKumar, Amit, Madhu Gupta i Simran Braya. "Liposome Characterization, Applications and Regulatory landscape in US". International Journal of Drug Regulatory Affairs 9, nr 2 (22.06.2021): 81–89. http://dx.doi.org/10.22270/ijdra.v9i2.474.
Pełny tekst źródłaGoins, Beth A., i William T. Phillips. "The Use of Scintigraphic Imaging During Liposome Drug Development". Journal of Pharmacy Practice 14, nr 5 (październik 2001): 397–406. http://dx.doi.org/10.1106/da2m-fyju-1xxq-ppkk.
Pełny tekst źródłaMarqués-Gallego, Patricia, i Anton I. P. M. de Kroon. "Ligation Strategies for Targeting Liposomal Nanocarriers". BioMed Research International 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/129458.
Pełny tekst źródłaAl Mutairi, Amal Abdullah, i Mohsen Mahmoud Mady. "Biophysical Characterization of (DOX-NPtm): FTIR and DSC Studies". JOURNAL OF ADVANCES IN PHYSICS 20 (3.03.2022): 41–47. http://dx.doi.org/10.24297/jap.v20i.9194.
Pełny tekst źródłaAbbase, Eman R., Medhat W. Shafaa i Mohsen M. Mady. "Competition Between Heparin and Polyethylene Glycol as Biofunctionalization for Improving Stability of Liposomal Doxorubicin". Advanced Science, Engineering and Medicine 12, nr 2 (1.02.2020): 271–77. http://dx.doi.org/10.1166/asem.2020.2496.
Pełny tekst źródłaHeneweer, Carola, Tuula Peñate Medina, Robert Tower, Holger Kalthoff, Richard Kolesnick, Steven Larson i Oula Peñate Medina. "Acid-Sphingomyelinase Triggered Fluorescently Labeled Sphingomyelin Containing Liposomes in Tumor Diagnosis after Radiation-Induced Stress". International Journal of Molecular Sciences 22, nr 8 (8.04.2021): 3864. http://dx.doi.org/10.3390/ijms22083864.
Pełny tekst źródłaRozprawy doktorskie na temat "Liposomes"
Heeremans, Anneke. "Liposomes in thrombolytic therapy : t-PA targeting with plasminogen-liposomes, a novel concept = Liposomen voor thrombolytische therapie /". [S.l. : s.n.], 1995. http://www.gbv.de/dms/bs/toc/186694245.pdf.
Pełny tekst źródłaThibault, Benoit. "Les liposomes : méthodes de préparation". Paris 5, 1990. http://www.theses.fr/1990PA05P177.
Pełny tekst źródłaLoughrey, Helen. "Targeted liposomes". Thesis, University of British Columbia, 1989. http://hdl.handle.net/2429/29180.
Pełny tekst źródłaMedicine, Faculty of
Biochemistry and Molecular Biology, Department of
Graduate
Mougin-Degraef, Marie Faivre-Chauvet Alain. "Les liposomes". [S.l.] : [s.n.], 2004. http://theses.univ-nantes.fr/thesemed/PHmougin.pdf.
Pełny tekst źródłaGyanani, Vijay. "Turning stealth liposomes into cationic liposomes for anticancer drug delivery". Scholarly Commons, 2013. https://scholarlycommons.pacific.edu/uop_etds/147.
Pełny tekst źródłaChen, Xiaoyu. "Investigation of liposomes and liposomal gel for prolonging the therapeutic effects of pharmaceutical ingredients". HKBU Institutional Repository, 2013. http://repository.hkbu.edu.hk/etd_ra/1524.
Pełny tekst źródłaRodríguez, Fernández Silvia. "Phosphatidylserine-rich liposomes to tackle autoimmunity. En route to translationality". Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/667944.
Pełny tekst źródłaAutoimmune diseases are caused by defective immunological tolerance, and reportedly affect up to 10% of the global population. In the last years, current medical interventions have transformed these disorders into chronic and manageable, but they still entail high rates of morbidity and mortality. Hence, there is an urgent need to develop therapies capable of restoring the breach of tolerance selectively, which halt the autoimmune aggression and allow the regeneration of the targeted tissue. In physiological conditions, the phagocytosis of apoptotic cells performed by phagocytes such as dendritic cells (DCs) —a process termed efferocytosis— prompts the acquisition of tolerogenic features and the ability to restore tolerance. Indeed, a cell immunotherapy consisting of DCs rendered tolerogenic (tolDCs) by apoptotic β-cell efferocytosis arrested the autoimmune attack against β-cells in an experimental model of type 1 diabetes (T1D). However, in light of the hurdles in obtaining and standardising human autologous apoptotic β-cells for its implementation in the clinics, a nanotherapeutic strategy based on liposomes mimicking apoptotic cells was designed. The fundamental characteristics of these synthetic vesicles are: a high percentage of phosphatidylserine (PS) —phospholipid unique to the apoptotic cell membrane—, diameter superior to 500 nm, negative charge and efficient encapsulation of insulin peptides. Importantly, this strategy was equally effective in inducing tolDCs and blunting β-cell autoimmunity as the immunotherapy based on apoptotic cells. The hypothesis of this work is that autoantigen-loaded PS-liposomes can re-establish tolerance in several antigen-specific autoimmune diseases through the induction of tolDCs and the expansion of regulatory T lymphocytes, and that they have translational potential to tackle human autoimmune disorders. The main aim of the present work has been to characterise the tolerogenic potential of PS-liposomes globally. To this end, different autoantigenic peptides relevant in autoimmune diseases have been efficiently encapsulated into PS-liposomes, without difficulties in preserving their appropriate diameter and charge, thus demonstrating the versatility of the therapy to different autoimmune pathologies. In the experimental model of T1D, the administration of PS-liposomes causes the expansion of clonal CD4+ regulatory T cells and CD8+ T cells, which contribute to the long-term re-establishment of tolerance. Moreover, in the same model, the biocompatibility and safety of the final product have been confirmed given its optimal tolerability. Furthermore, PS-liposomes have been adapted to the experimental multiple sclerosis model by merely replacing the encapsulated autoantigen. In this model, PS-liposomes elicit the generation of tolDCs and decrease the incidence and severity of the disease correlating with an increase in the frequency of regulatory T cells, a fact that validates the potential of PS-liposomes to serve as a platform for tolerance re-establishment in different autoimmune diseases. Finally, considering its future clinical implementation, the effect of the PS-liposomes therapy has been determined in human DCs obtained from patients with T1D. In DCs from adult patients, PS-liposomes are efficiently phagocyted by DCs with rapid kinetics dependent on the presence of PS, and this induces a tolerogenic transcriptome, phenotype and functionality that are similar to those observed in experimental models. However, DCs from paediatric patients display defects in their phagocytic capacity correlating with the time of disease progression, albeit their phenotype and immunoregulatory gene expression after PS-liposomes phagocytosis point to an optimal tolerogenic ability. In conclusion, the liposomal immunotherapy herein described, which is based on efferocytosis as a powerful tolerance-inducing mechanism, achieves apoptotic mimicry in a simple, safe and efficient manner. Additionally, liposomes offer advantages in terms of production and standardisation. Therefore, PS-liposomes possess translational potential and constitute an encouraging strategy to restore immunological tolerance in antigen-specific autoimmune diseases.
Bohl, Kullberg Erika. "Tumor Cell Targeting of Stabilized Liposome Conjugates : Experimental studies using boronated DNA-binding agents". Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3435.
Pełny tekst źródłaWhite, Karen Louise, i n/a. "Modified liposomes as adjuvants". University of Otago. School of Pharmacy, 2005. http://adt.otago.ac.nz./public/adt-NZDU20070126.131417.
Pełny tekst źródłaFrost, S. J. "Analytical applications of liposomes". Thesis, University of Surrey, 1994. http://epubs.surrey.ac.uk/2745/.
Pełny tekst źródłaKsiążki na temat "Liposomes"
Nejat Du zgu nes ʹ. Liposomes. San Diego: Elsevier Academic Press, 2009.
Znajdź pełny tekst źródłaʹ, Nejat Du zgu nes. Liposomes. Amsterdam: Elsevier, 2009.
Znajdź pełny tekst źródłaD'Souza, Gerard G. M., red. Liposomes. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6591-5.
Pełny tekst źródłaWeissig, Volkmar, red. Liposomes. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-447-0.
Pełny tekst źródłaWeissig, Volkmar, red. Liposomes. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60327-360-2.
Pełny tekst źródłaD'Souza, Gerard G. M., i Hongwei Zhang, red. Liposomes. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2954-3.
Pełny tekst źródłaNejat, Düzgünes, red. Liposomes. San Diego, Calif: Academic Press, 2003.
Znajdź pełny tekst źródłaOstro, Marc J. Liposomes. New York: Scientific American, 1987.
Znajdź pełny tekst źródłaNejat, Düzgüneş, red. Liposomes. San Diego, CA: Elsevier Academic Press, 2005.
Znajdź pełny tekst źródłaNejat, Düzgüneş, red. Liposomes. Amsterdam: Elsevier Academic Press, 2003.
Znajdź pełny tekst źródłaCzęści książek na temat "Liposomes"
Moghimi, Seyed Moein. "Liposomes". W Encyclopedia of Nanotechnology, 1802–8. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-017-9780-1_95.
Pełny tekst źródłaTadros, Tharwat. "Liposomes". W Encyclopedia of Colloid and Interface Science, 682. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-20665-8_114.
Pełny tekst źródłaVergara-Irigaray, Nuria, Michèle Riesen, Gianluca Piazza, Lawrence F. Bronk, Wouter H. P. Driessen, Julianna K. Edwards, Wadih Arap i in. "Liposomes". W Encyclopedia of Nanotechnology, 1218–23. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-90-481-9751-4_95.
Pełny tekst źródłaOku, Naoto. "Liposomes". W ACS Symposium Series, 24–33. Washington, DC: American Chemical Society, 1991. http://dx.doi.org/10.1021/bk-1991-0469.ch003.
Pełny tekst źródłaKalra, Jessica, i Marcel B. Bally. "Liposomes". W Fundamentals of Pharmaceutical Nanoscience, 27–63. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9164-4_3.
Pełny tekst źródłaStanzl, Klaus. "Liposomes". W Novel Cosmetic Delivery Systems, 233–66. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003418078-12.
Pełny tekst źródłaSantana, Maria Helena A., i Beatriz Zanchetta. "Elastic Liposomes". W Nanocosmetics and Nanomedicines, 139–62. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-19792-5_7.
Pełny tekst źródłaAryasomayajula, Bhawani, Giuseppina Salzano i Vladimir P. Torchilin. "Multifunctional Liposomes". W Methods in Molecular Biology, 41–61. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6646-2_3.
Pełny tekst źródłaStano, Pasquale, i Pier Luigi Luisi. "Reactions in Liposomes". W Molecular Encapsulation, 455–91. Chichester, UK: John Wiley & Sons, Ltd, 2010. http://dx.doi.org/10.1002/9780470664872.ch17.
Pełny tekst źródłaOzcetin, Aybike, Samet Mutlu i Udo Bakowsky. "Archaebacterial Tetraetherlipid Liposomes". W Methods in Molecular Biology, 87–96. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-360-2_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Liposomes"
Zeimer, Ran C., Bahram Khoobehi, Gholam A. Peyman, Richard L. Magin i Michael R. Niesman. "Externally Controlled Delivery of Dyes in the Eye: A Potential New Method to Assess Retinal Blood Circulation". W Noninvasive Assessment of the Visual System. Washington, D.C.: Optica Publishing Group, 1988. http://dx.doi.org/10.1364/navs.1988.thb1.
Pełny tekst źródłaLee, Eunice S., Christel M. Munoz, Blake A. Simmons, C. R. Bowe Ellis i Rafael V. Davalos. "Feasibility Study on the Use of Temperature-Dependent Liposomes for Variable Concentration Profiles in Drug Delivery Applications". W ASME 2004 International Mechanical Engineering Congress and Exposition. ASMEDC, 2004. http://dx.doi.org/10.1115/imece2004-61303.
Pełny tekst źródłaZhang, Aili, Xipeng Mi i Lisa X. Xu. "Study of Thermally Targeted Nano-Particle Drug Delivery for Tumor Therapy". W ASME 2008 First International Conference on Micro/Nanoscale Heat Transfer. ASMEDC, 2008. http://dx.doi.org/10.1115/mnht2008-52383.
Pełny tekst źródłaMatsuyama, R., K. Nobusue, N. Arai, T. Honda, M. Komiya, A. Hirano-Iwata i M. Sadgrove. "Localization of lipid vesicles near a thin optical fiber". W Optical Manipulation and Its Applications. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/oma.2023.ath1d.3.
Pełny tekst źródłaTartis, Michaelann S., Jan Marik, Azadeh Kheirolomoom, Rachel E. Pollard, Hua Zhang, Jinyi Qi, Julie L. Sutcliffe i Katherine W. Ferrara. "Pharmacokinetics of Encapsulated Paclitaxel: Multi-Probe Analysis With PET". W ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176435.
Pełny tekst źródłaPopova, O. S. "Nanoparticles as a transport system for corvacrol compounds". W SPbVetScience. FSBEI HE St. Petersburg SUVM, 2023. http://dx.doi.org/10.52419/3006-2023-8-64-67.
Pełny tekst źródłaLarsen, Jannik. "Single liposome fluorescent imaging reveal heterogeneous pegylation of drug delivery liposomes". W European Microscopy Congress 2020. Royal Microscopical Society, 2021. http://dx.doi.org/10.22443/rms.emc2020.1008.
Pełny tekst źródłaZhang, Shu, Lachlan Gibson, Daryl Preece, Timo A. Nieminen i Halina Rubinsztein-Dunlop. "Viscoelasticity measurements inside liposomes". W SPIE NanoScience + Engineering, redaktorzy Kishan Dholakia i Gabriel C. Spalding. SPIE, 2014. http://dx.doi.org/10.1117/12.2060938.
Pełny tekst źródłaNoguchi, Akemi, Chiaki Kojima, Ken-ichi Yuyama, Tatsuya Shoji i Yasuyuki Tsuboi. "Laser-induced microbubble fusion of liposomes and formation of ultralong tubes". W Conference on Lasers and Electro-Optics/Pacific Rim. Washington, D.C.: Optica Publishing Group, 2022. http://dx.doi.org/10.1364/cleopr.2022.ctup16e_05.
Pełny tekst źródłaEnzian, Paula, Astrid Link, Christian Schell, Carina Malich i Ramtin Rahmanzadeh. "Light-induced permeabilization of liposomes". W 17th International Photodynamic Association World Congress, redaktor Tayyaba Hasan. SPIE, 2019. http://dx.doi.org/10.1117/12.2526071.
Pełny tekst źródłaRaporty organizacyjne na temat "Liposomes"
Joyce, Christine, i Deidre Mountain. Optimization of Liposomal Encapsulation Efficiency. University of Tennessee Health Science Center, 2021. http://dx.doi.org/10.21007/com.lsp.2018.0002.
Pełny tekst źródłaCheng, Yung-Sung, C. R. Lyons i M. H. Schmid. Delivery of aerosolized drugs encapsulated in liposomes. Office of Scientific and Technical Information (OSTI), grudzień 1995. http://dx.doi.org/10.2172/381350.
Pełny tekst źródłaVanderMeulen, David L., Prabhakar Misra, Jason Michael, Kenneth G. Spears i Mustafa Khoka. Laser Mediated Release of Dye form Liposomes,. Fort Belvoir, VA: Defense Technical Information Center, styczeń 1992. http://dx.doi.org/10.21236/ada249203.
Pełny tekst źródłaAuthor, Not Given. DNA Repair Enzyme-Liposomes: Human Skin Cancer Prevention. Office of Scientific and Technical Information (OSTI), wrzesień 1999. http://dx.doi.org/10.2172/770453.
Pełny tekst źródłaSanthosh, Poornima, Julia Genova, Ales Iglič, Veronika Kralj-Iglič i Nataša Poklar Ulrih. Influence of Cholesterol on Bilayer Fluidity and Size Distribution of Liposomes. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, lipiec 2020. http://dx.doi.org/10.7546/crabs.2020.07.07.
Pełny tekst źródłaZakrevskiy, V. I., N. G. Plekhanova i V. I. Smirnova. Entrapping of Hydrophobized Plague Capsular Antigen into the Large Unilamellar Liposomes. Fort Belvoir, VA: Defense Technical Information Center, styczeń 1991. http://dx.doi.org/10.21236/ada241775.
Pełny tekst źródłaAlving, Carl R. Lipid A and Liposomes Containing Lipid A as Adjuvants for Vaccines. Chapter 18. Fort Belvoir, VA: Defense Technical Information Center, styczeń 1993. http://dx.doi.org/10.21236/ada272664.
Pełny tekst źródłaOnyuksel, Hayat. Tc-99m Labeled and VIP Receptor Targeted Liposomes for Effective Imaging of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2004. http://dx.doi.org/10.21236/ada433960.
Pełny tekst źródłaZakrevskiy, V. I., i N. G. Plekhanova. Study of Protective Properties of Antigen-Containing Liposomes of Varying Lipid Composition in Plague. Fort Belvoir, VA: Defense Technical Information Center, styczeń 1991. http://dx.doi.org/10.21236/ada241778.
Pełny tekst źródłaTaylor, Kenneth M. The Effect of Cholesterol on the Binding and Insertion of Cytochrome b5 into Liposomes of Phosphatidylcholines. Fort Belvoir, VA: Defense Technical Information Center, sierpień 1993. http://dx.doi.org/10.21236/ad1011298.
Pełny tekst źródła